CoLabs

CoLabs Int'l, Corp. was founded in 2008 and is a global leader in highly charged, natural, microencapsulated technologies for targeted delivery in OTC drugs, pharmaceuticals, and agrochemicals. The company is a mid-stage biotechnology firm based in Nevada, with executive offices in Huntington Beach, California. CoLabs' technology places medications into microcapsules that are electrostatically charged and suspended within a unique formulation. This highly advanced technology minimizes unnecessary absorption of drugs and cosmetics through the skin. The sophisticated microtechnology formulation can: target the delivery of topically applied medications; limit unnecessary absorption of chemicals, drugs, and cosmetics through the skin; and provide controlled release of active ingredients with specified skin penetration depths. CoLabs has developed commercially unique and innovative targeted skin delivery systems for topical pharmacology. CoLabs' technology reduces unnecessary side effects caused by skin absorption. Chemical penetration through the skin may severely impact the body’s organs and systems. CoLabs’ current applications include antibacterial/viral disinfectants/soaps, sunscreens, insect repellents, and healing cosmetic lotions. For consumers, CoLabs offers elegant skin delivery for topical medications and cosmetics.